Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Burton

Showing results (1021-1030 of 1,376) with videos related to

Pageof 138
Sort By:
Frontiers in Immunology|September 9, 2017
Hidden Lineage Complexity of Glycan-Dependent HIV-1 Broadly Neutralizing Antibodies Uncovered by Digital Panning and Native-Like gp140 TrimerLinling He, Xiaohe Lin, Natalia de Val, et al.
Diabetes|February 27, 2008
On the pathogenicity of autoantigen-specific T-cell receptorsAmanda R Burton, Erica Vincent, Paula Y Arnold, et al.
STAR Protocols|May 6, 2022
Isolation of human intrahepatic leukocytes for phenotypic and functional characterization by flow cytometryStephanie Kucykowicz, Oliver E Amin, Alice R Burton, et al.
Journal of Virology|May 25, 2007
A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivoJohn V Williams, Zhifeng Chen, Gabriella Cseke, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2011
Rapid development of glycan-specific, broad, and potent anti-HIV-1 gp120 neutralizing antibodies in an R5 SIV/HIV chimeric virus infected macaqueLaura M Walker, Devin Sok, Yoshiaki Nishimura, et al.
Science Translational Medicine|March 18, 2021
Effector function does not contribute to protection from virus challenge by a highly potent HIV broadly neutralizing antibody in nonhuman primatesLars Hangartner, David Beauparlant, Eva Rakasz, et al.
Immunity|September 22, 2021
A Cre-driven allele-conditioning line to interrogate CD4<sup>+</sup> conventional T cellsLawrence P Andrews, Kate M Vignali, Andrea L Szymczak-Workman, et al.
Plos Pathogens|August 13, 2015
Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal AntibodiesLaura E McCoy, Emilia Falkowska, Katie J Doores, et al.
Nature Medicine|December 8, 2007
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challengeMansun Law, Toshiaki Maruyama, Jamie Lewis, et al.
Pharmacoeconomics|November 11, 2024
Value-Based Healthcare in Practice: IDEATE, a Collaboration to Design and Test an Outcomes-Based Agreement for a Medicine in WalesJessica R Burton, Kate Halsby, Graciela Sáinz de la Fuente, et al.
Pageof 138

Showing results (1021-1030 of 1,376) with videos related to

Sort By:
Pageof 138
Frontiers in Immunology|September 9, 2017
Hidden Lineage Complexity of Glycan-Dependent HIV-1 Broadly Neutralizing Antibodies Uncovered by Digital Panning and Native-Like gp140 TrimerLinling He, Xiaohe Lin, Natalia de Val, et al.
Diabetes|February 27, 2008
On the pathogenicity of autoantigen-specific T-cell receptorsAmanda R Burton, Erica Vincent, Paula Y Arnold, et al.
STAR Protocols|May 6, 2022
Isolation of human intrahepatic leukocytes for phenotypic and functional characterization by flow cytometryStephanie Kucykowicz, Oliver E Amin, Alice R Burton, et al.
Journal of Virology|May 25, 2007
A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivoJohn V Williams, Zhifeng Chen, Gabriella Cseke, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2011
Rapid development of glycan-specific, broad, and potent anti-HIV-1 gp120 neutralizing antibodies in an R5 SIV/HIV chimeric virus infected macaqueLaura M Walker, Devin Sok, Yoshiaki Nishimura, et al.
Science Translational Medicine|March 18, 2021
Effector function does not contribute to protection from virus challenge by a highly potent HIV broadly neutralizing antibody in nonhuman primatesLars Hangartner, David Beauparlant, Eva Rakasz, et al.
Immunity|September 22, 2021
A Cre-driven allele-conditioning line to interrogate CD4<sup>+</sup> conventional T cellsLawrence P Andrews, Kate M Vignali, Andrea L Szymczak-Workman, et al.
Plos Pathogens|August 13, 2015
Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal AntibodiesLaura E McCoy, Emilia Falkowska, Katie J Doores, et al.
Nature Medicine|December 8, 2007
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challengeMansun Law, Toshiaki Maruyama, Jamie Lewis, et al.
Pharmacoeconomics|November 11, 2024
Value-Based Healthcare in Practice: IDEATE, a Collaboration to Design and Test an Outcomes-Based Agreement for a Medicine in WalesJessica R Burton, Kate Halsby, Graciela Sáinz de la Fuente, et al.
Pageof 138